Tadalafil Tablet
Product Images NDC 63629-8288

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 63629-8288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636298288)

Label for Tadalafil 5 mg oral tablets, packaged by Bryant Ranch Prepack, Burbank, CA. The label compares this product to Cialis 5 mg tablets by Ajanta Pharma Limited. It includes storage instructions to keep at 20°-25°C (68°-77°F) and a warning to keep the drug out of reach of children. The label indicates the package contains 30 tablets and shows a barcode with NDC 63629-8288.*

FDA Label Image

Figure8 (Tadalafil Fig8)

A line graph comparing the change from baseline in IPSS Total Score over a 12-week treatment duration between Tadalafil 5 mg and placebo groups. The graph shows a greater decrease in IPSS score with Tadalafil 5 mg treatment compared to placebo, with data points indicated at weeks 0, 2, 4, 8, and 12. Statistical significance (p<0.01) is noted at week 12.*

FDA Label Image

Figure1 (Tadalafil Figure1)

Four line graphs depicting blood pressure differences over time comparing tadalafil to placebo. The charts show standing systolic and diastolic blood pressure and supine systolic and diastolic blood pressure across a 96-hour period, measured in millimeters of mercury (mmHg), with data points and error bars illustrating variability in readings.*

FDA Label Image

Figure2 (Tadalafil Figure2)

Two line graphs showing changes in systolic blood pressure (mmHg) over 24 hours post-dose. The top graph displays standing systolic BP changes, and the bottom graph shows supine systolic BP changes. The graphs compare effects of Tadalafil 20 mg with doxazosin 8 mg versus placebo with doxazosin 8 mg over time.*

FDA Label Image

Figure3 (Tadalafil Figure3)

A line graph showing the change in systolic blood pressure (mmHg) over 12 hours after administration of tadalafil or placebo, combined with doxazosin. The graph compares 20 mg tadalafil and placebo given at 08:00 and 20:00, with continuous measurements plotted over time.*

FDA Label Image

Figure4 (Tadalafil Figure4)

A line graph showing plasma tadalafil concentration (μg/L) versus time (hours) for different dosing regimens: single 20-mg dose, single 5-mg dose, and once-daily 5-mg dose following 5 consecutive days of administration. The graph displays the concentration decline over a 120-hour period with error bars for variability.*

FDA Label Image

Figure5 (Tadalafil Figure5)

A line graph showing the change from baseline in IPSS total score over 12 weeks of treatment. It compares Tadalafil 5 mg tablets to a placebo, with time (weeks) on the horizontal axis and change in IPSS score on the vertical axis. The graph indicates a greater improvement in IPSS score with Tadalafil 5 mg than placebo.*

FDA Label Image

Figure6 (Tadalafil Figure6)

A line graph showing change from baseline in IPSS total score over treatment duration in weeks, comparing Tadalafil 5 mg tablets versus placebo. The Tadalafil group shows a greater decrease in score over 12 weeks, with a statistical significance noted at p<0.01.*

FDA Label Image

Figure7 (Tadalafil Figure7)

A line graph depicting the least-squares mean change from baseline over 26 weeks of therapy. It compares Tadalafil/Finasteride versus Placebo/Finasteride, with data points at 0, 4, 12, and 26 weeks. The graph includes statistical notations for significance (p<0.001 and p<0.05).*

FDA Label Image

Structure (Tadalafil Structure)

Chemical structure of Tadalafil showing the detailed molecular arrangement with various rings including a benzodioxole group and a piperidine moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.